Cargando…

Gridlock from diagnosis to treatment of multidrug resistant tuberculosis (MDR-TB) in Tanzania: patients’ perspectives from a focus group discussion

BACKGROUND: Molecular diagnostics have revolutionized the diagnosis of multidrug resistant tuberculosis (MDR-TB). Yet in Tanzania we found delay in diagnosis with more than 70% of MDR-TB patients having a history of several previous treatment courses for TB signaling prior opportunities for diagnosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mpagama, Stellah G., Ezekiel, Mangi J., Mbelele, Peter M., Chongolo, Anna M., Kibiki, Gibson S., de Guex, Kristen Petros, Heysell, Scott K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648291/
https://www.ncbi.nlm.nih.gov/pubmed/33160327
http://dx.doi.org/10.1186/s12889-020-09774-3
_version_ 1783607086684307456
author Mpagama, Stellah G.
Ezekiel, Mangi J.
Mbelele, Peter M.
Chongolo, Anna M.
Kibiki, Gibson S.
de Guex, Kristen Petros
Heysell, Scott K.
author_facet Mpagama, Stellah G.
Ezekiel, Mangi J.
Mbelele, Peter M.
Chongolo, Anna M.
Kibiki, Gibson S.
de Guex, Kristen Petros
Heysell, Scott K.
author_sort Mpagama, Stellah G.
collection PubMed
description BACKGROUND: Molecular diagnostics have revolutionized the diagnosis of multidrug resistant tuberculosis (MDR-TB). Yet in Tanzania we found delay in diagnosis with more than 70% of MDR-TB patients having a history of several previous treatment courses for TB signaling prior opportunities for diagnosis. We aimed to explore patients’ viewpoints and experiences with personal and socio-behavioral obstacles from MDR-TB diagnosis to treatment in an attempt to understand these prior findings. METHODS: The study was conducted in December 2016 with MDR-TB patients admitted at Kibong’oto Infectious Diseases Hospital. A qualitative approach deploying focus group discussions (FGDs) was used to gather information. Groups were sex aggregated to allow free interaction and to gauge gender specific issues in the social and behavioral contexts. The FGDs explored pathways and factors in the service delivery that may have contributed in the delay in accessing MDR-TB diagnostics and/or treatment. Collected data were coded, categorized and thematically interpreted. RESULTS: Forty MDR-TB patients participated in six FGDs. Challenges and barriers contributing to the delay in accessing MDR-TB diagnosis to treatment were as follows: 1) Participants had a different understanding of MDR-TB that led to seeking services outside the conventional health system; 2) Socio-economic adversity made health-seeking behavior difficult and often unproductive; 3) In the health system, challenges included inadequacy of MDR-TB diagnostic centers, lack of knowledge on behalf of health care providers to consider MDR-TB and order appropriate diagnostics; 4) The specimen referral system for early diagnosis of MDR-TB was inefficient. Non-adherence of TB patients to first-line anti-TB drugs prior to MDR-TB diagnosis, given the multitude of barriers discussed, was coupled with both intentional and unintentional non-adherence of health care providers to international standards of TB care. CONCLUSION: Patient-centered strategies bridging communities and the health system are urgently required for optimum MDR-TB control in Tanzania. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-020-09774-3.
format Online
Article
Text
id pubmed-7648291
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-76482912020-11-09 Gridlock from diagnosis to treatment of multidrug resistant tuberculosis (MDR-TB) in Tanzania: patients’ perspectives from a focus group discussion Mpagama, Stellah G. Ezekiel, Mangi J. Mbelele, Peter M. Chongolo, Anna M. Kibiki, Gibson S. de Guex, Kristen Petros Heysell, Scott K. BMC Public Health Research Article BACKGROUND: Molecular diagnostics have revolutionized the diagnosis of multidrug resistant tuberculosis (MDR-TB). Yet in Tanzania we found delay in diagnosis with more than 70% of MDR-TB patients having a history of several previous treatment courses for TB signaling prior opportunities for diagnosis. We aimed to explore patients’ viewpoints and experiences with personal and socio-behavioral obstacles from MDR-TB diagnosis to treatment in an attempt to understand these prior findings. METHODS: The study was conducted in December 2016 with MDR-TB patients admitted at Kibong’oto Infectious Diseases Hospital. A qualitative approach deploying focus group discussions (FGDs) was used to gather information. Groups were sex aggregated to allow free interaction and to gauge gender specific issues in the social and behavioral contexts. The FGDs explored pathways and factors in the service delivery that may have contributed in the delay in accessing MDR-TB diagnostics and/or treatment. Collected data were coded, categorized and thematically interpreted. RESULTS: Forty MDR-TB patients participated in six FGDs. Challenges and barriers contributing to the delay in accessing MDR-TB diagnosis to treatment were as follows: 1) Participants had a different understanding of MDR-TB that led to seeking services outside the conventional health system; 2) Socio-economic adversity made health-seeking behavior difficult and often unproductive; 3) In the health system, challenges included inadequacy of MDR-TB diagnostic centers, lack of knowledge on behalf of health care providers to consider MDR-TB and order appropriate diagnostics; 4) The specimen referral system for early diagnosis of MDR-TB was inefficient. Non-adherence of TB patients to first-line anti-TB drugs prior to MDR-TB diagnosis, given the multitude of barriers discussed, was coupled with both intentional and unintentional non-adherence of health care providers to international standards of TB care. CONCLUSION: Patient-centered strategies bridging communities and the health system are urgently required for optimum MDR-TB control in Tanzania. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-020-09774-3. BioMed Central 2020-11-07 /pmc/articles/PMC7648291/ /pubmed/33160327 http://dx.doi.org/10.1186/s12889-020-09774-3 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Mpagama, Stellah G.
Ezekiel, Mangi J.
Mbelele, Peter M.
Chongolo, Anna M.
Kibiki, Gibson S.
de Guex, Kristen Petros
Heysell, Scott K.
Gridlock from diagnosis to treatment of multidrug resistant tuberculosis (MDR-TB) in Tanzania: patients’ perspectives from a focus group discussion
title Gridlock from diagnosis to treatment of multidrug resistant tuberculosis (MDR-TB) in Tanzania: patients’ perspectives from a focus group discussion
title_full Gridlock from diagnosis to treatment of multidrug resistant tuberculosis (MDR-TB) in Tanzania: patients’ perspectives from a focus group discussion
title_fullStr Gridlock from diagnosis to treatment of multidrug resistant tuberculosis (MDR-TB) in Tanzania: patients’ perspectives from a focus group discussion
title_full_unstemmed Gridlock from diagnosis to treatment of multidrug resistant tuberculosis (MDR-TB) in Tanzania: patients’ perspectives from a focus group discussion
title_short Gridlock from diagnosis to treatment of multidrug resistant tuberculosis (MDR-TB) in Tanzania: patients’ perspectives from a focus group discussion
title_sort gridlock from diagnosis to treatment of multidrug resistant tuberculosis (mdr-tb) in tanzania: patients’ perspectives from a focus group discussion
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648291/
https://www.ncbi.nlm.nih.gov/pubmed/33160327
http://dx.doi.org/10.1186/s12889-020-09774-3
work_keys_str_mv AT mpagamastellahg gridlockfromdiagnosistotreatmentofmultidrugresistanttuberculosismdrtbintanzaniapatientsperspectivesfromafocusgroupdiscussion
AT ezekielmangij gridlockfromdiagnosistotreatmentofmultidrugresistanttuberculosismdrtbintanzaniapatientsperspectivesfromafocusgroupdiscussion
AT mbelelepeterm gridlockfromdiagnosistotreatmentofmultidrugresistanttuberculosismdrtbintanzaniapatientsperspectivesfromafocusgroupdiscussion
AT chongoloannam gridlockfromdiagnosistotreatmentofmultidrugresistanttuberculosismdrtbintanzaniapatientsperspectivesfromafocusgroupdiscussion
AT kibikigibsons gridlockfromdiagnosistotreatmentofmultidrugresistanttuberculosismdrtbintanzaniapatientsperspectivesfromafocusgroupdiscussion
AT deguexkristenpetros gridlockfromdiagnosistotreatmentofmultidrugresistanttuberculosismdrtbintanzaniapatientsperspectivesfromafocusgroupdiscussion
AT heysellscottk gridlockfromdiagnosistotreatmentofmultidrugresistanttuberculosismdrtbintanzaniapatientsperspectivesfromafocusgroupdiscussion